Database for congenital lung anomalies in Switzerland
Follow up of Congenital Lung Anomalies (CLA) With Antenatal Diagnosis - a Swiss Multicentric Database
University Hospital, Geneva · NCT03044769
This study is creating a detailed database of congenital lung anomalies in Switzerland to help doctors understand these rare conditions better and support future research and treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | N/A to 16 Years |
| Sex | All |
| Sponsor | University Hospital, Geneva (other) |
| Locations | 1 site (Geneva) |
| Trial ID | NCT03044769 on ClinicalTrials.gov |
What this trial studies
This project aims to create a comprehensive database of congenital lung anomalies by pooling cases from various Swiss medical centers. It will register clinical, biological, radiological, and histological data in a secure, multicentric database. The study involves a multidisciplinary team of specialists and aims to improve understanding of these rare conditions, their evolution, and potential biomarkers. Additionally, a tissue biobank will be established to support future research and treatment development.
Who should consider this trial
Good fit: Ideal candidates for this study are all patients diagnosed with congenital lung anomalies.
Not a fit: Patients without a diagnosis of congenital lung anomalies will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols and innovative therapies for patients with congenital lung anomalies.
How similar studies have performed: While this approach is novel in the context of a Swiss database, similar studies have shown success in pooling data for rare conditions to improve understanding and treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients diagnosed with congenital lung anomalies Exclusion Criteria: * None
Where this trial is running
Geneva
- Geneva University Hospital — Geneva, Switzerland (RECRUITING)
Study contacts
- Principal investigator: Isabelle Andrieu Vidal, MD PhD — University Hospital, Geneva
- Study coordinator: Isabelle Ruchonnet-Métrailler, MD PhD
- Email: isabelle.ruchonnet-metrailler@hcuge.ch
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Congenital Lung Malformation, Congenital Lung Cyst, Sequestrum, Bronchogenic Cancer, Pleuropulmonary Blastoma, Acinar Dysplasia, Congenital Lung Anomalies